# i&i Bio

i&i Bio is a Private Equity based in Luxembourg, Luxembourg.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Luxembourg, Luxembourg
- **Region:** Europe
- **Address:** Luxembourg, Luxembourg
- **Founded:** 2021
- **Assets under management:** Undisclosed
- **Website:** inibio.eu
- **LinkedIn:** https://www.linkedin.com/company/i-i-biotech-fund

## Regulatory record

- **Reports private funds:** No

## About

i&i Bio is structured as a Luxembourg-based private equity firm focused on early-stage through growth-stage investments in life sciences, with a particular emphasis on biotechnology and related health sectors. The firm's formation reflects a broader movement in European venture to anchor promising academic discoveries with committed, specialist capital, although specific founding principals and the vehicle's precise inception date remain opaque in public record. Investment activity spans seed, start-up, and growth stages, with the firm targeting co-investment opportunities alongside institutional partners, university technology-transfer offices, and European research consortia. i&i Bio's mandate concentrates on therapeutics, medical devices, and enabling technologies sourced primarily from institutions across the European Union. The firm deploys via direct equity and structured co-investment vehicles, positioning as a specialist rather than a generalist financial sponsor. The firm maintains its registered office in Luxembourg, a jurisdiction that has increasingly attracted private equity and venture structures seeking regulatory passporting benefits across the EU. No public disclosures detail total headcount, committed capital, or specific portfolio companies, reflecting either early-stage organizational maturation or deliberate operational opacity common among specialist investment firms that prioritize deal-level discretion.

## Sectors

- Life Sciences
- Drug Discovery
- MedTech
- Diagnostics
- AI/ML

## People

- Karel Kubias — Founding Partner
- Ivan Vohlmuth — Founding Partner
- Barbora Šumová — Partner
- Tomáš Maršálek — Founding Partner

## Questions

### Who runs investment decisions at i&i Bio?

Investment decisions are led by Founding Partners Karel Kubias, Ivan Vohlmuth, and Tomáš Maršálek, alongside Partner Barbora Šumová. Kubias brings 20 years of life sciences executive experience, Vohlmuth has overseen over 100 investments across CEE, and Maršálek specializes in fund management and valuations. The team comprises seven professionals including an associate and an advisor.

### How does i&i Bio source proprietary deal flow?

The firm is embedded in the innovation ecosystem around the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Science, providing access to preclinical research and academic spinouts. It also scouts broadly across Europe for early-stage life science ventures, focusing on Central and Eastern Europe but open to pan-European opportunities. The portfolio includes companies from drug discovery, medtech, diagnostics, and AI verticals.

### What investment stages does i&i Bio typically target?

The fund targets early-stage ventures from seed to growth, with a starting ticket of €150,000 for business creation and a sweet spot between €0.5M and €2M for scaling rounds. Portfolio companies include both preclinical-stage biotech startups and those advancing into clinical trials, such as Captain T Cell and T-CURX. i&i Bio also retains capacity to follow on for exceptional performers.

### Which sectors does i&i Bio explicitly focus on?

i&i Bio focuses exclusively on life sciences, with specific verticals including drug discovery, medtech, diagnostics, and AI-driven biotech. The firm explicitly avoids generalist tech or non-life sciences investments. Its portfolio spans drug discovery platforms, medtech devices, diagnostic tools, and AI applications for drug discovery, as reflected in companies like Antiverse, HeartBeat.bio, and Theorema.

## Related profiles

- [i-Hatch Ventures](https://altss.com/profile/i-hatch-ventures)
- [IIDIC](https://altss.com/profile/iidic)

---

Last updated: 2026-08-11T02:43:31.692Z

Canonical page: https://altss.com/profile/i-i-bio

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology